trimetazidine has been researched along with pentylenetetrazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharal, N; Jain, S; Khurana, S; Mediratta, PK; Sharma, KK | 1 |
| Abdel-Kawy, HS; El Serafy, OMH; Hasanin, AH; Hassan, OA; Raafat, MH; Sedky, AA | 1 |
2 other study(ies) available for trimetazidine and pentylenetetrazole
| Article | Year |
|---|---|
Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice.
Topics: Animals; Anticonvulsants; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Glutathione; Kindling, Neurologic; Male; Malondialdehyde; Mice; Oxidative Stress; Pentylenetetrazole; Trimetazidine | 2011 |
Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.
Topics: Animals; Anticonvulsants; Aorta; Biomarkers; Blood Glucose; Drug Synergism; Epilepsy; Hippocampus; Insulin; Insulin Resistance; Kindling, Neurologic; Liver; Male; Oxidative Stress; Pentylenetetrazole; Rats; Rats, Wistar; Trimetazidine; Valproic Acid | 2017 |